Genentech Inc.
Division of Roche
www.gene.com
Latest From Genentech Inc.
Asia Begins To See Impact From Roche 'De-Siloing'
As part of a global strategy first unveiled last year, Roche is taking concrete steps to restructure its pharma operations in Asia, including the substantial downsizing of a Singapore office.
US PTO's Patent Eligibility Guidance Draws Industry Plaudits, Request For More Specifics
BIO, PhRMA, Novartis, Amgen, and Genentech suggest revisions to guidance on hot-button issue of subject matter patent eligiblity; patent owners group says 'best approach' is to enact legislation to restore patent eligibility law.
Gyroscope Merger Creates Gene Therapy Biotech For Eye Disorders
South Korea's ADEL Innovates With Anti-Tau Antibody For Alzheimer’s Disease
Emerging Company Profile: ADEL Inc. CEO Seung-Yong Yoon tells Scrip how its anti-tau antibody brings something different to the table in the challenging field of Alzheimer's disease and what's in store for the South Korean bioventure.
Company Information
- Industry
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Gastrointestinal
- Immune Disorders
- Infectious & Viral Diseases
- Metabolic Disorders
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Ophthalmic
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Roche
- Senior Management
-
Alexander Hardy, CEO
Ed Harrington, CFO
Sandra J Horning, MD, EVP, Global Dev. & CMO - Contact Info
-
Genentech Inc.
Phone: (650) 225-1000
1 DNA Way
S. San Francisco, CA 94080
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice